Windward Bio Group AG Common Shares (WWB)
WWB trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · November 16, 2026
$30.04
+5.40% on the day
Market cap
$1.7B
Small cap
Revenue
No annual revenue in SEC XBRL data for this filer
Net income
No annual revenue in SEC XBRL data for this filer
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | WWB on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | Switzerland |
| IPO year | 2026 |
| SEC CIK | 0002145089 |
| SEC industry code | Biological Products, (No Diagnostic Substances) (SEC code, stale: periodic reports ended never filed) |
| Incorporated in | Switzerland |
Financials
No annual revenue in SEC XBRL data for this filer.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2026-11-16 |
Source: SEC EDGAR submissions feed, 24 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ALVO | Alvotech | $4.41 | +5.13% | $1.7B |
| RXRX | Recursion Pharmaceuticals Inc. | $2.90 | -8.79% | $1.8B |
| COAG | Hemab Therapeutics Holdings Inc. | $39.05 | -4.42% | $1.8B |
| VIR | Vir Biotechnology Inc. | $9.58 | -3.82% | $1.6B |
| MAZE | Maze Therapeutics Inc. | $33.90 | -1.25% | $1.9B |
| MESO | Mesoblast Limited | $12.45 | -6.18% | $1.6B |
| BCRX | BioCryst Pharmaceuticals Inc. | $7.45 | -2.10% | $1.9B |
| REPL | Replimune Group Inc. | $21.41 | -2.19% | $2.0B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier